Recent pre-clinical studies demonstrate that inhibition of NOTCH1 using synthetic stapled peptides or monoclonal antibody-mediated strategies effectively decreases T-ALL cell line growth [22], [23]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.